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Abstract
Diagnostic imaging plays a key role in the diagnosis 
and management of inflammatory bowel disease 
(IBD). However due to the relapsing nature of IBD, 
there is growing concern that IBD patients may be 
exposed to potentially harmful cumulative levels of 
ionising radiation in their lifetime, increasing malignant 
potential in a population already at risk. In this review 
we explore the proportion of IBD patients exposed 
to high cumulative radiation doses, the risk factors 
associated with higher radiation exposures, and 
we compare conventional diagnostic imaging with 
newer radiation-free imaging techniques used in the 
evaluation of patients with IBD. While computed 
tomography (CT) performs well as an imaging modality 
for IBD, the effective radiation dose is considerably 
higher than other abdominal imaging modalities. It 
is increasingly recognised that CT imaging remains 
responsible for the majority of diagnostic medical 
radiation to which IBD patients are exposed. Magnetic 
resonance imaging (MRI) and small intestine contrast 
enhanced ultrasonography (SICUS) have now emerged 
as suitable radiation-free alternatives to CT imaging, 
with comparable diagnostic accuracy. The routine use 
of MRI and SICUS for the clinical evaluation of patients 
with known or suspected small bowel Crohn’s disease 
is to be encouraged wherever possible. More provision 
is needed for out-of-hours radiation-free imaging 
modalities to reduce the need for CT.
Key words: Diagnostic medical radiation; Inflammatory 
bowel disease; Small bowel follow-through; Com-
puterised tomography; Nuclear medicine; Magnetic 
resonance enterography; Small intestine contrast-
enhanced ultrasonography
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Core tip: Due to the chronic and relapsing nature of 
inflammatory bowel disease (IBD), patients are at risk 
of exposure to potentially harmful cumulative radiation 
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Table 1  Radiation doses from gastrointestinal imaging studies 
in comparison to background radiation, condensed from 
RadiologyInfo.org[9] and Mettler et al [10]
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doses in their lifetime. Computed tomography (CT) 
imaging remains responsible for the majority of this 
radiation exposure. As well as new reduced radiation 
CT imaging techniques, radiation-free alternatives 
magnetic resonance imaging and small intestine 
contrast enhanced ultrasonography have emerged, 
offering comparable diagnostic accuracy. In this review 
we explore the proportion of IBD patients exposed to 
high cumulative radiation doses, the factors associated 
with higher radiation exposures, and we compare 
conventional imaging with newer radiation-free 
imaging techniques for the evaluation of patients with 
IBD.
Zakeri N, Pollok RCG. Diagnostic imaging and radiation 
exposure in inflammatory bowel disease. World J Gastroenterol 
2016; 22(7): 2165-2178  Available from: URL: http://www.
wjgnet.com/1007-9327/full/v22/i7/2165.htm  DOI: http://dx.doi.
org/10.3748/wjg.v22.i7.2165
INTRODUCTION
Inflammatory bowel disease (IBD), consisting of 
ulcerative colitis (UC) and Crohn’s disease (CD), is 
a chronic relapsing-remitting inflammatory disorder 
of the gastrointestinal tract. The prevalence of IBD 
is increasing worldwide, with 2.2 million and 1.4 
million people affected in Europe and United States 
respectively[1].
Diagnostic imaging is required to aid the diagnosis 
of IBD, assess disease extent and severity, detect 
complications including extra-intestinal manifestations, 
and monitor response to treatment. Due to the 
relapsing nature of IBD, multiple imaging studies 
are often required. Despite this, in clinical practice 
cumulative exposure to radiation is not routinely 
monitored.
Patients with IBD have an increased lifetime risk 
of developing colorectal and small intestinal cancers, 
irrespective of diagnostic radiation exposure[2,3]. There 
is growing concern that repeated X-ray based imaging 
may additionally expose this typically young cohort 
of patients to harmful cumulative levels of ionising 
radiation, further increasing their lifetime cancer risk.
In this article we review the proportion of IBD 
patients exposed to potentially harmful cumulative 
radiation doses and the risk factors associated with 
higher radiation exposures. We explore and compare 
conventional diagnostic imaging and newer radiation-
free imaging techniques for the evaluation of patients 
with IBD.
RaDIaTION ExpOsURE aND CaNCER 
RIsk
Extensive study of the atomic bomb survivors from 
Hiroshima and Nagasaki has formed the basis for 
quantitative estimates of radiation-induced cancer 
risk. In this large cohort of survivors, the rates of solid 
cancer deaths were positively associated with higher 
radiation doses and younger age of exposure[4,5]. In a 
2012 study of the atomic bomb survivors, the relative 
risk of solid cancers increased by 29% per decade 
decrease in the initial age of radiation exposure[5]. 
Younger people appear to be inherently more radio-
sensitive, and have more remaining life-years during 
which a cancer may develop[4].
It is estimated that diagnostic medical radiation 
(DMR) exposure may be responsible for up to 2% of 
cancers worldwide[6]. Younger patients and females 
appear to have the greatest radiation-induced cancer 
risk[7]. Epidemiological data suggests that ionising 
radiation levels as low as 50 millisieverts (mSv) have 
been implicated in the development of solid tumours[8]. 
Potentially harmful radiation exposure is, therefore, 
commonly defined as cumulative effective dose 
(CED) > 50 mSv; the equivalent of five computed 
tomography (CT) abdominal-pelvis scans. A reference 
table comparing radiation exposure doses of common 
diagnostic gastrointestinal imaging techniques is 
included in Table 1[9,10].
CUmUlaTIvE RaDIaTION ExpOsURE IN 
IBD paTIENTs
Several published studies have attempted to quantify 
the proportion of IBD patients exposed to potentially 
harmful cumulative levels of ionising radiation (sum-
marised in Table 2). Desmond et al[11] first evaluated 
DMR exposure in 354 patients with CD in a single 
tertiary centre in Ireland. CT imaging accounted for 
77.2% of the total DMR exposure. The mean CED 
was 36.1 mSv and exceeded 75 mSv in 15.5% of 
patients. More recently, a meta-analysis by Chatu et 
Imaging procedure Average 
effective dose 
(mSv)
Time period for equivalent 
effective dose from natural 
background radiation1
Multiphase CT abdomen 
and pelvis
31 10.3 yr
PET/CT 25 8.3 yr
CT Abdomen and Pelvis 10 3.3 yr
CT Colonography 10 3.3 yr
CT Abdomen   8 2.7 yr
Barium Enema   8 2.7 yr
Small bowel follow-
through
  5 1.7 yr
X-ray abdomen 0.7 2.8 mo
1Based on the assumption of an average effective dose of 3 mSv per year 
from natural background radiation. CT: Computed tomography; PET: 
Positron emission tomography.
Table 2  Quantification of the cumulative effective dose of diagnostic radiation received by IBD patients, and factors associated with 
high cumulative radiation exposure (cumulative effective dose > 50 mSv); adapted from Chatu et al [12] with permission
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Study Number of 
patients (n )
Country Design Patient 
population
Outcome CED 
≥ 50 mSv
Mean/Median 
CED (mSv)
Factors associated with high 
radiation exposure
Newnham et al[59], 2007 100 (62 CD, 
37 UC, 1 
indeterminate 
colitis)
Australia Retrospective study, 
single tertiary centre, 
patients recruited 
consecutively from 
clinic
Adult
(16-84 yr)
11/100 (11%) 9 
CD, 2 UC
Median CED 
10 mSv
Assessed: age, gender, 
disease, disease duration, 
previous surgery, 
immunomodulator use, 
referral source
Significant: none
Desmond et al[11], 2008 354 CD Ireland Retrospective study, 
single tertiary centre, 
patients recruited 
from IBD database 
July 1992-June 2007
Adult and 
paediatric 
(8.6-78.3 yr)
CED ≥ 75 
mSv in 55/354 
patients (15.5%)
Mean CED 
36.1 mSv
Assessed: age, gender, 
smoking, FH, disease 
distribution, disease 
behaviour, medication, 
surgical history
Significant: age < 17 at 
diagnosis, upper GI tract 
disease, penetrating disease, 
requirement for Ⅳ steroids, 
infliximab use, multiple 
surgeries
Peloquin et al[18], 2008 215 (103 CD, 
112 UC)
United States Retrospective study, 
population based 
inception cohort 
diagnosed between 
1991 to 2001 from 
Olmsted County
Adult and 
paediatric 
(1.2-91.4 yr)
N/A Median CED
CD: 26.6 mSv
UC: 10.5 mSv
N/A
Levi et al[60], 2009 324 (199 CD, 
125 UC)
Israel Retrospective study, 
single tertiary centre, 
patients diagnosed 
Jan 1999-Dec 2006, 
recruited from IBD 
database
Adult and 
paediatric 
≤ 17 yr 
(18) > 18 yr 
(306)
23/324 (7.1%) Mean CED
CD: 21.1mSv
UC: 15.1mSv
Assessed: age, surgery, 
diagnosis, medical therapy, 
disease duration, gender
Significant: CD, surgery, 
prednisolone use, disease 
duration, first year of 
disease, age
Palmer et al[61], 2009 1593 (965 CD, 
628 UC)
United States Retrospective study, 
population based 
cohort recruited 
from insurance 
claims database Jan 
2003-December 2004
Paediatric 
(2-18 yr)
N/A (34% 
CD, 23% UC 
exposed to 
moderate 
radiation - at 
least 1 CT or 
3 fluoroscopic 
procedures)
N/A Assessed: age, gender, 
region, hospitalisation, 
surgery, ED encounter, 
medication
Significant: hospitalisation, 
inpatient GI surgery, ED 
encounter, use of steroids
Kroeker et al[62], 2011 553 (371 CD, 
182 UC)
Canada Retrospective study, 
single tertiary centre, 
patients diagnosed 
2003-2008, recruited 
from IBD database
Adult and 
paediatric 
(15-84 yr)
28/553 (5%) 27 
CD, 1 UC
Mean CED
CD: 14.3 mSv
UC: 5.9 mSv
Assessed: age at 
diagnosis, gender, disease 
distribution, previous 
surgery
Significant: previous 
surgery
Fuchs et al[63], 2011 257 (171 CD, 86 
UC)
United States Retrospective study Paediatric 
(< 18 yr)
15/257 (5.8%) 14 
CD, 1UC
Mean CED Assessed in CD cohort: 
gender, disease behaviour, 
previous surgery, disease 
duration, elevated platelet 
count at diagnosis
Significant: previous 
surgery, elevated platelet 
count at diagnosis
Sauer et al[64], 2011 117 (86 CD, 31 
UC)
United States single tertiary centre, 
patients reviewed
Jan-May 2008
Retrospective study, 
single tertiary centre, 
patients diagnosed 
2002-2008
Paediatric 
(2-18 yr)
6/117 (5%) 6 CD CD: 20.5 mSv
UC: 11.7 mSv
Median CED
CD: 15.6 mSv
UC: 7.2 mSv
N/A
Zakeri N et al . Imaging and radiation exposure in IBD
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al[12], evaluated six studies including a total of 1704 
IBD patients. It reported a pooled estimate of 8.4% 
of IBD patients receiving high dose radiation exposure 
(CED > 50 mSv). More patients with CD (11.1%) were 
exposed to high cumulative radiation doses (CED > 50 
mSv) than patients with UC (2%)[12].
Similar trends have been found in studies following 
this meta-analysis. A 2015 retrospective review of 
325 IBD patients in Chile, reported 19.5% of patients 
with CD and 2.4% of patients with UC, to be exposed 
to CED > 50 mSv[13]. A recent United Kingdom 
retrospective study of 415 patients with IBD referred 
from primary care, reported a median total CED of 
7.2 mSv in CD patients and 2.8 mSv in UC patients, 
with 8% of IBD patients overall exposed to CED > 50 
mSv. Kaplan Meier analysis projected a probability 
Huang et al[65], 2011 105 (61 CD, 
32 UC, 12 
indeterminate 
colitis)
United States Single tertiary 
paediatric centre, 
patients identified 
from medical 
records
Paediatric 
cohort (11 
mo-18 yr)
6/105 (6%) Mean CED 15 
mSv
Assessed: surgery, disease 
type, disease location, 
racioethnic background, 
anti TNF agents, use of 
immunomodulators, 
hospital admissions, age at 
diagnosis
Significant: CD, small 
bowel involvement, 
black ethnicity, number 
of hospital admissions, 
previous surgery, anti TNF 
alpha use
Butcher et al[17], 2012 280 United 
Kingdom
Retrospective study, 
Single tertiary 
centre, consecutive 
patients attending 
IBD clinic
Adult 
cohort
6.3% CD Mean CED 
10.17 mSv 
Median CED 
4.12 mSv
Significant: smoking status, 
disease duration, previous 
surgery
Jung et al[15], 2013 2199 (777 CD, 
1422 UC)
South Korea Retrospective 
study, multicentre 
conducted at 13 
university hospitals 
in South Korea, 
patients diagnosed 
July 1987-Jan 2012 
included
Adult 
cohort 
(Mean age: 
CD 29.2 yr; 
UC 42.2 yr)
34.7% CD, 8.4% 
UC
Mean CED
CD: 53.6 mSv
UC: 16.4 mSv
Assessed: gender, age at 
diagnosis, disease duration, 
disease extent, surgery, 
hospitalisation, 5-ASA use, 
steroids, immunomodulator 
use
Significant: For CD - 
longer disease duration, 
ileocolonic disease, upper 
GI tract involvement, 
surgery, hospitalisation, 
steroids
For UC - surgery, 
hospitalisation, infliximab 
use
Chatu et al[14], 2013 415 (217 CD, 
198 UC)
United 
Kingdom
Retrospective study, 
single tertiary 
centre, patients 
consecutively 
recruited from clinic 
Jan 2011- June 2011
Adult 
cohort 
(Mean age: 
CD 30.8 yr; 
UC 36.9 yr)
32/415 (8%) 29 
CD, 3 UC
Median CED 
CD: 7.2 mSv
UC: 2.8 mSv
Assessed: gender, age 
at diagnosis, disease 
type, steroid use within 
3 mo diagnosis, use of 
immunomodulators or 
biologics, extraintestinal 
features, IBD related 
surgery
Significant: males, IBD 
related surgery
Estay et al[13], 2015 325 (82 CD, 243 
UC)
Chile Retrospective study, 
patients recruited 
from IBD Registry 
2011-2013
Adult 
cohort 
(16-86 yr)
22/325 (6.8%): 
CD 16 (19.5%); 
UC 6 (2.5%)
Mean CED 
11.97 mSv
CD: 29.9 mSv
UC: 5.92 mSv
Assessed in CD cohort 
only: age at diagnosis, 
disease duration, disease 
location, disease behaviour, 
perianal disease, surgery, 
hospitalisation, medications
Significant: longer disease 
duration, ileal involvement, 
stricturing disease, 
treatment with steroids 
and biological agents, CD 
related hospitalisation or 
surgery
UC: Ulcerative colitis; CD: Crohn’s disease; IBD: Inflammatory bowel disease; CED: Cumulative effective dose; mSv: Milisieverts of radiation; ED: 
Emergency department; FH: Family history.
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of exposure to CED > 50 mSv of 6% and 14% at 10 
years and 15 years from IBD diagnosis respectively 
(figure 1)[14].
Concerningly, a retrospective study of IBD patients 
in South Korea, conducted across 13 university hos-
pitals, reported even higher proportions of patients 
exposed to potentially harmful radiation levels. 34.7% 
of patients with CD and 8.4% of patients with UC were 
exposed to CED > 50 mSv[15]. CT imaging accounted 
for the vast majority of this radiation exposure (81.6% 
of the total CED in CD vs 71.2% in UC)[15], indicating 
that overuse of CT imaging remains a concern 
worldwide, and may reflect limited availability or lack 
of awareness of preferable imaging modalities.
Despite the high proportion of IBD patients 
exposed to high radiation doses, cumulative radiation 
exposures are not routinely recorded in clinical 
practice. The creation of IBD radiation diaries has 
been proposed to log total radiation exposures[16], and 
improve recognition among physicians where a patient 
has previously been exposed to ionising radiation.
FaCTORs assOCIaTED wITh 
INCREasED RaDIaTION ExpOsURE IN 
IBD paTIENTs
Risk factors for high radiation exposure in IBD patients 
have been widely studied[11-15,17]. In a cohort of 354 
adult and paediatric patients with CD, Desmond et al[11] 
identified that patients diagnosed under the age of 
17, patients with upper gastrointestinal (GI) disease, 
penetrating disease, multiple surgeries, or those that 
required intravenous steroids or infliximab, were at 
greater risk of receiving high cumulative radiation 
exposure. Following this, a 2012 meta-analysis of five 
studies evaluating risk factors in 2627 IBD patients, 
found a significant association with only previous IBD 
related surgery and corticosteroid use. The pooled 
adjusted odds ratios were 5.4 and 2.4, respectively[12].
Across studies, patients with CD consistently appear 
to receive higher cumulative radiation exposures than 
patients with UC, possibly due to a greater likelihood 
of extraluminal complications commonly examined by 
CT. After adjusting for time since symptom onset, a 
retrospective study by Peloquin et al[18] (2008) found 
patients with CD to be exposed to 2.46 times more 
diagnostic radiation than patients with UC (median 
CED 26.6 mSv in CD vs 10.5 mSv in UC).
A summary of outcomes from studies investigating 
predictive factors for high radiation exposure in 
IBD patients is provided in Table 2. While there are 
discrepancies regarding the significance of some 
associations, the majority of the risk factors described 
are surrogate markers of disease activity and severity. 
It is therefore apparent that patients with more severe 
disease, who are more likely to receive corticosteroids 
and require surgery, undergo more diagnostic imaging 
including greater use of CT imaging, to guide further 
management.
DIagNOsTIC ImagINg mODalITIEs IN 
IBD
Small bowel follow-through
A 2011 survey revealed small bowel follow-through 
(SBfT) to be the most frequently performed investi-
gation in the United Kingdom for the assessment of 
small bowel CD[19]. CT was predominantly performed 
for suspected extra-luminal complications or 
obstruction[19]. SBfT and small bowel enteroclysis 
(SBE) have, for many years, been the routine first-
line imaging modalities to evaluate small bowel 
involvement in patients with suspected or confirmed 
CD. Both SBfT and SBE have similar sensitivities 
(85%-95%) and specificities (89%-94%) for detecting 
radiological features of CD[20]. SBfT is usually preferred 
for patient tolerance, since nasal or oral intubation is 
not required. However, these techniques both employ 
ionising radiation and appear to have lower diagnostic 
accuracy compared to newer cross-sectional imaging 
modalities[21,22].
In a 2005 United States study, SBfT had a lower 
diagnostic yield for mild to moderate CD compared 
to CT enterography, video capsule endoscopy and 
ileoscopy[21]. A 2009 Korean study of 30 patients with 
CD, found a significantly lower sensitivity of SBFT for 
the detection of extra-enteric complications (p < 0.01), 
although no significant difference in the detection of 
active terminal ileitis, compared to CT and magnetic 
resonance enterography (MRE)[22]. Barium based 
studies may still have a role to play in the evaluation 
of small bowel CD, but are increasingly being replaced 
by alternative imaging modalities such as CT, MRE and 
small bowel ultrasound.
CT
In the United States, CT has largely superseded 
Figure 1  Kaplan Meier analysis showing the cumulative probability of 
being exposed to cumulative effective dose > 50 mSv from diagnosis 
according to inflammatory bowel disease type (Chatu et al[14], 2013).
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SBfT as the preferred first-line imaging modality for 
CD. Between 2002 and 2007, there was a reported 
840% increase in the use of CT enterography in IBD 
patients in Minnesota, United States[6]. Similarly, a 
310% increase in use of abdominal CT imaging was 
reported in a United Kingdom study of IBD patients 
between 1990 and 2010[14]. CT imaging offers the 
advantages of widespread availability, rapid acquisition 
of images, high sensitivity and specificity for the 
detection of intramural and extra-intestinal disease, as 
well as being well tolerated by patients[4]. The effective 
radiation dose is, however, considerably higher than 
other abdominal imaging modalities (Table 1)[9,10]. The 
United States National Research Council estimates that 
one out of every 1000 patients undergoing a 10 mSv 
CT scan will develop a radiation-induced cancer in their 
lifetime [23].
Conventional CT abdominal-pelvis imaging is 
typically used for the detection of extra-intestinal 
complications of IBD, such as abscesses, fistula, bowel 
obstruction or perforation. It may have a limited role 
in the assessment of colonic disease activity. A small 
study by Patel et al[24] of 23 patients with UC (2012), 
identified positive correlation of contrast-enhanced 
CT features (bowel wall thickening, mucosal hyper-
enhancement and mural stratification), compared with 
clinical assessment (p < 0.05) and colonoscopy (p < 
0.0001) in evaluating UC disease severity. However, 
only increasing bowel wall thickness on CT correlated 
with histological disease severity[24].
Conventional CT is limited in its assessment of 
small bowel inflammation due to artefact produced 
from collapsed bowel loops. CT enterography (CTE) is 
a newer imaging technique, combining high resolution 
CT scanning with mutiplanar reconstructions after 
administration of an oral and parenteral contrast which 
acts to promote bowel loop distension. This improves 
visualisation of the small bowel mucosa, enabling 
more accurate assessment of small bowel disease 
activity[25]. High correlation has been shown between 
quantitative measures of bowel wall thickness and 
terminal ileal mural attenuation at CTE compared 
with ileocolonoscopy and histological analysis in active 
CD[26]. furthermore, CTE may be a useful adjunct 
to ileocolonoscopy. In a 2012 study of 153 patients 
with CD in the United States, CTE detected active 
small bowel disease in 36 of the 67 patients (54%) 
with normal ileoscopy appearances. The negative 
ileoscopy results were largely due to disease “skipping” 
of the terminal ileum, or confinement to intramural 
or mesenteric distal ileum. CTE also detected extra-
colonic CD in 26% of patients[27].
Data for the benefit of CTE in assessing colonic 
disease is limited. A small study analysing CTE in 35 
patients with inflammatory colitis, identified a sensitivity 
of 93% and specificity of 91% for the detection 
of moderate to severe disease in well-distended 
colons. However, there was a tendency for CTE to 
underestimate the full extent and severity of colonic 
disease[28].
CT colonography (CTC) is an emerging imaging 
technique developed for colonic evaluation. While 
colonoscopy remains standard practice for the 
assessment of colonic disease, CTC may offer advan-
tages where colonoscopy is incomplete or contra-
indicated. The majority of data comparing CTC and 
colonoscopy has been obtained from studies detecting 
colorectal cancer[25]. Only a few studies have investi-
gated the efficacy of CTC in IBD, hence its role is not 
clearly defined. A small German prospective study 
of 21 IBD patients suggested sensitivities of 63.6% 
and 100% for the identification of acute and chronic 
IBD by CTC, with a specificity of 75% and 100% 
respectively[29]. CTC requires full bowel preparation, 
as well as air or carbon dioxide insufflation for colonic 
distension, and therefore is not always well tolerated. 
There have been reported cases of CTC-induced bowel 
perforation as well. Although the perforation rate is 
low, at around 0.04%, CTC is generally avoided in the 
acute phase of IBD[30].
Unfortunately while CT performs very well as an 
imaging modality there is an emerging recognition that 
it is responsible for the majority of the total radiation 
dose to which IBD patients are exposed[11-13,15]. Indeed 
in a recent study from Chile, abdominal-pelvic CT 
and CT enteroclysis accounted for 93.6% of the total 
CED exposure[13]. Excessive use of CT imaging in IBD 
patients presenting to the emergency department (ED) 
has also raised concern. In a study from the United 
States, no significant findings were observed in 32.8% 
of CT imaging studies carried out in IBD patients in the 
ED[31]. Preliminary algorithms to avoid inappropriate 
use of CT imaging in IBD patients presenting to the ED 
have been proposed and require validation[31,32].
Reduced radiation dose CT
Due to concerns regarding high radiation exposure 
from CT imaging, recent developments in technology 
have paved the way for strategies to reduce the 
radiation dose associated with CT imaging, without 
compromising diagnostic imaging quality. These 
techniques include tube current (mA) modulation, 
lowering tube potential modulation (kV), and 
minimising the number of dynamic CT phases[33]. 
Multiphase CT abdomen and pelvis imaging exposes 
a patient to around 31 mSv, equivalent to over three 
times the radiation dose of standard CT abdominal-
pelvis imaging[9]. Single-phase CTE is in most cases 
believed to be sufficient to evaluate small bowel CD[33]. 
Reduced radiation CT techniques may help to lessen 
cumulative radiation exposures and bridge the gap in 
situations where radiation-free imaging is not widely 
available.
Nuclear medicine imaging
Technetium-99-m hexamethyl-propyleneamine oxime 
(99mTc-HMPAO) labeled white blood cell scintigraphy is 
an imaging technique that employs radioactive isotopes 
Zakeri N et al . Imaging and radiation exposure in IBD
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to detect active inflammation[34]. It may be used in IBD 
to assess disease activity, but due to limited availability 
and high cost, it is not routinely performed. 99mTc-
HMPAO white cell scintigraphy can visualise the entire 
GI tract and emits a lower radiation dose than CT (2-4 
mSv)[35]. Reported uses include evaluating responses 
to treatment and differentiating between disease 
relapse and fibrotic tissue post surgery[36]. It also has 
a role in assessing disease extent in acute severe 
colitis, where colonoscopy is usually contra-indicated. 
A United Kingdom study by Subramanian et al[37] of 
135 patients with UC, noted substantial correlation (k 
= 0.7) between 99mTc-HMPAO white cell scintigraphy 
and histological assessment of the proximal extent of 
disease involvement in patients with UC. Scintigraphy 
performed better than colonoscopy (p = 0.02) in 
assessing patients with more extensive colitis, while 
colonoscopy predicted disease extent more accurately 
in patients with limited colitis (p = 0.002)[37].
Positron emission tomography (PET) is a non-
invasive nuclear imaging technique that provides 
three dimensional, quantitative imaging. It is primarily 
used for tumour staging, though preliminary data has 
shown it may have some value in the diagnosis of 
IBD[38,39]. PET imaging is expensive and its availability 
is limited to certain centres. Data on the potential role 
of fluorine-18-fluorodeoxyglucose/PET (18f-fDG/PET) 
and PET/CT in IBD is limited and requires further 
review. Routine use of PET/CT for IBD assessment is 
unlikely due to the high doses of radiation involved 
(table 1)[9,10].
RaDIaTION-FREE DIagNOsTIC ImagINg 
mODalITIEs
In view of the concerns over cumulative radiation 
exposure in IBD patients, alternative radiation-
free imaging strategies have emerged as a focus of 
interest, and are increasingly being favoured in clinical 
practice. Studies comparing the diagnostic accuracies 
for radiation-free imaging vs conventional imaging 
modalities in small bowel CD are summarised in Table 
3.
A 2008 meta-analysis by Horsthuis et al[40] com-
paring magnetic resonance imaging (MRI), ultra-
sonography (US), scintigraphy and CT across 33 
studies, showed high per-patient sensitivity for 
the diagnosis of IBD with no significant differences 
between imaging modalities. Mean sensitivity 
estimates were 93%, 90%, 88% and 84% for MRI, 
US, white cell scintigraphy and CT respectively. Per-
patient specificity was also high and comparable 
across imaging modalities: 93%, 96%, 85% and 95% 
for MRI, US, scintigraphy and CT respectively. The 
only significant difference was a lower specificity for 
scintigraphy compared to US (p = 0.009)[40]. Mean per-
bowel-segment sensitivity estimates were lower across 
all imaging modalities (70%, 74%, 77% and 68% for 
MRI, US, scintigraphy and CT respectively). Per-bowel-
segment analysis showed CT to be significantly less 
sensitive and specific compared to MRI (p = 0.037) 
and scintigraphy (p = 0.006)[40]. More recently, a 2011 
systematic review by Panés et al[41] also compared US, 
MRI and CT for the assessment of disease location and 
extension in CD. Overall, US had superior diagnostic 
accuracy for the detection of disease localised to the 
terminal ileum and colon, while MRI performed better 
than US for the detection of CD lesions in the jejunum 
and proximal ileum. CT and MRI demonstrated 
similar diagnostic accuracy for the assessment of CD 
extension and activity[41].
MRE
MRE is a non-invasive technique used to obtain 
cross-sectional imaging of the small bowel without 
exposure to diagnostic medical radiation. MRE 
provides superior soft tissue contrast resolution 
compared to CTE, allowing detailed visualisation of 
inflammatory and fibrotic bowel wall[42]. A 2011 Italian 
prospective study by fiorino et al[43] compared MRE 
and CTE in 44 patients with ileocolonic CD. They 
found comparable accuracy between MRE and CTE in 
localising CD, assessing bowel wall thickening, bowel 
wall enhancement and enteroenteric fistula. However, 
MRE was superior to CTE in detecting strictures (p = 
0.04) and ileal wall enhancement (p = 0.02). A 2014 
meta-analysis by Qiu et al[44] of 290 CD patients across 
six studies, found no significant difference between the 
diagnostic accuracy of MRE and CTE in detecting active 
small bowel CD and its complications including fistula, 
stenosis and abscess formation.
Given its proven diagnostic accuracy, updated 
guidelines by the European Crohn’s and Colitis 
Organisation and the European Society of Gastro-
intestinal and Abdominal Radiology, advocate increased 
routine usage of MRI for the assessment of small 
bowel CD, to reduce radiation exposure in this cohort 
of patients[45].
Recently, diagnostic indices from MRE have been 
developed to attempt to quantify disease severity. 
The magnetic resonance index of activity score has 
demonstrated a significant correlation with the CD 
endoscopic index of severity[42]. In perianal CD, MRI 
remains the preferred imaging modality, permitting 
accurate diagnosis and staging of perianal fistula[42]. 
Drawbacks of MR imaging, however, include higher 
procedure costs, lengthy acquisition times and limited 
availability, particularly out of routine working hours.
The efficacy of MR Colonography (MRC) for the 
evaluation of colonic disease activity in IBD is less 
well defined. A 2005 study comparing MRC using 
contrast gadolinium enemas, to standard colonoscopy 
in 22 patients with suspected or known IBD revealed 
disappointing results, with a per-segment sensitivity of 
58.8% and 31.6% for identifying colonic inflammation 
in UC and CD respectively[46]. Other studies have 
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Study Country Number of 
patients (n )
Design Imaging compared Study findings
Low et al[66], 2000 United States 26 CD Prospective study, Contrast enhanced 
MR with single phase 
CT using findings 
from surgery, barium 
studies, endoscopic 
and histological 
findings as reference 
standard
Side-by-side comparison: MR imaging superior 
than helical CT in depiction of normal bowel 
wall, mural thickening or enhancement and 
overall GI tract evaluation
MR images showed 55 (85%) and 52 (80%) of 65 
abnormal bowel segments for the two observers, 
compared with helical CT which showed 39 
(60%) and 43 (65%) of bowel segments affected 
by CD (P < 0.001, P < 0.05)
Maconi et al[67], 2003 Italy 128 CD Single centre
Prospective study,
consecutive CD patients 
who underwent surgery 
immediately after 
diagnostic work-up
US, barium studies, 
CT to detect 
internal fistulae and 
intra-abdominal 
abscesses compared 
to intraoperative 
findings
Detecting internal fistula: comparable diagnostic 
accuracy of US (85.2%) and barium X-ray (84.8%) 
studies
Sensitivity US (71.4%), X-ray (69.6%),
Specificity US (95.8%), X-ray (95.8%)
Detection of abscesses: US (90.9%), CT (86.4%)
Overall diagnostic accuracy higher with CT than 
US (91.8% vs 86.9%) due to false positives with 
US
Parente et al[49], 2004 Italy 102 CD Prospective study,
consecutive patients 
with proven CD by BE 
and ileocolonoscopy 
enrolled from IBD clinic 
Dec 2002-July 2003
Adult cohort (≥ 18 yr)
Conventional US 
vs oral contrast 
enhanced US, 
compared to BE and 
ileocolonoscopy as 
gold standard
Per segment analysis: Superior diagnostic 
accuracy of contrast US in detecting small bowel 
CD. Sensitivity: conventional US 91.4%, contrast 
US 96.1%
Good correlation of disease extent measurements 
with BE: US (r = 0.83), contrast US (r = 0.94)
Higher sensitivity and specificity with contrast 
US in detecting ≥ 1 small bowel strictures: 
Sensitivity: US (74%), contrast US (88.8%)
Specificity: US (93.3%), contrast Us (97.3%)
US and contrast US more accurate in detecting 
internal fistulas than BE, but no significant 
difference in diagnostic accuracy between US 
and contrast US. US (80%), contrast US (86%), BE 
(67%)
Significantly improved interobserver variability 
between sonographers with contrast US for 
detecting bowel wall thickness and disease 
location
Calabrese et al[55], 2005 Italy 28 CD Prospective study,
consecutive patients 
recruited from IBD clinic
Adult cohort (age range 
21-60 yr)
SICUS (performed 
by a sonologist of 
1 yr experience) vs 
TUS (performed 
by an experienced 
sonologist of 10 
yr experience), 
compared to SBE as 
gold standard
Sensitivity for detection of small bowel lesions: 
96% TUS, 100% SICUS
Greater correlation of extension of lesions 
between SICUS and SBE (r = 0.88) vs TUS and 
SBE (r = 0.64)
Sensitivity for detection of ≥ 1 stricture: 76% 
TUS, 94% SICUS
Sensitivity and specificity for assessing 
prestenotic dilatation: 50% and 100% for TUS, vs 
100% and 90% for SICUS
Horsthuis et al[40], 2007 Amsterdam 1735 
(sample 
size 15-440)
Meta-analysis of 33 
prospective studies 
published between
Jan 1993- Feb 2006
Adult and paediatric 
cohort
(age range 2-86 yr)
US, MRI, 
scintigraphy, CT
US evaluated in 11 
studies, MRI in 11, 
scintigraphy in 9 and 
CT in 7 studies
Per-patient analysis: Significantly lower 
specificity for scintigraphy vs US. No significant 
difference between mean sensitivities for 
diagnosis of IBD
Sensitivities: 89.7% US, 93% MRI, 87.8% 
scintigraphy, 84.3% CT
Specificities: 95.6% US, 92.8% MR, 84.5% 
scintigraphy, 95.1% CT
Per bowel segment analysis: Significantly lower 
sensitivity and specificity for CT compared 
to scintigraphy and MRI. Sensitivities: 73.5% 
US, 70.4% MRI, 77.3% scintigraphy, 67.4% 
CT. Specificities: 92.9% US, 94% MRI, 90.3% 
scintigraphy, 90.2% CT
Zakeri N et al . Imaging and radiation exposure in IBD
2173 February 21, 2016|Volume 22|Issue 7|WJG|www.wjgnet.com
Lee et al[22], 2009 South Korea 30 CD Prospective study,
single centre,
consecutive patients with 
known or suspected CD 
enrolled
Adult cohort (age range 
18-44 yr)
MRE, CT, SBFT 
for detection of 
active small bowel 
inflammation 
and extraenteric 
complications with 
ileocolonoscopy as 
reference standard
No significant difference between CTE, MRE 
and SBFT for the detection of active terminal 
ileitis. Sensitivity CTE (89%), MRE (83%), SBFT 
(67%-72%)
Significantly higher sensitivity for MRE (100%) 
and CTE (100%) compared to SBFT (32% reader 
1, 37% reader 2) for the detection of extraenteric 
complications
Siddiki et al[68], 2009 United States 33 CD Prospective blinded 
study, single centre, 
consecutive
patients with suspected 
active small bowel CD 
April 2005-May 2008
Adult cohort
(age range 20-63 yr)
MRE, CTE compared 
with ileocolonoscopy
No significant difference between sensitivity of 
MRE (90.5%) and CTE (95.2%) in detecting active 
small bowel CD
In 8 cases (24%) MRE and CTE identified active 
small bowel inflammation not detected at 
ileocolonoscopy
MRE significantly lower image quality score 
than CTE
Ippolito et al[69], 2009 Italy 29 CD Prospective study,
Single centre, 
symptomatic patients 
with proven CD and 
suspected relapse, 
recruited from outpatient 
clinic
Adult and paediatric 
cohort (age range 14-70 
yr)
Mean age 43.8 yr
Contrast MRE and 
contrast multi-
detector CTE
Complete agreement between MRE and CTE in 
classification of disease activity (k = 1)
Good level of agreement between MRE 
and CTE for wall thickening and mucosal 
hyperenhancement (k = 1), comb (k = 0.9) and 
halo signs (k = 0.86)
CTE superior to MRE in detecting fibrofatty 
proliferation (P = 0.045)
MRE depicted higher number of fistulas than 
CTE but non-significant (P = 0.083)
Schreyer et al[70], 2010 Germany 53 CD Retrospective study,
Single centre,
Patients with advanced 
CD and acute abdominal 
pain attending the 
emergency department
Adult cohort
Conventional CT, 
MRE
No significant difference in image quality 
between CT and MRE
No significant difference in diagnosis of small 
bowel inflammation between CT (69.4%) and 
MRE (71.4%)
CT detection of lymph nodes significantly higher 
than MRE
No significant difference in detection of fistulae 
(CT n = 25, MRE n = 27) or abscesses (CT n = 32, 
MRE n = 32)
Panés et al[41], 2011 Spain N/A Systematic review of 
68 prospective studies, 
minimum 15 patients per 
study
US, CT, MRI for 
diagnosis of CD, 
assessment of 
disease extent and 
activity, detection of 
complications
Sensitivity for diagnosis of suspected CD and 
evaluation of disease activity: US 84%, MRI 93%
Specificity for diagnosis of suspected CD and 
evaluation of disease activity: US 92%, MRI 90%
CT similar accuracy to MRI for assessment of 
disease activity and extension. US accuracy 
lower for disease proximal to terminal ileum
US, CT, MRI all high accuracy for detection 
of fistulas, abscesses, stenosis. US higher false 
positive for abscesses
Fiorino et al[43], 2011 Italy 44 CD Prospective study,
Single centre, 
consecutive patients 
with ileocolonic CD 
requiring endoscopic or 
radiological evaluation
Enrolled 2006-2009
Adult cohort (> 18 yr)
Mean age 44 yr
CTE and MRE to 
assess disease activity 
and complications in 
ileocolonic CD, using 
ileocolonoscopy as 
reference standard
MRE significantly superior to CTE in detecting 
internal strictures: sensitivity (92% vs 85%), 
accuracy (95% vs 91%), specificity (90% vs 51%)
Overall no significant difference in sensitivity 
and specificity of MRE and CTE in localising CD, 
bowel wall thickening, bowel wall enhancement, 
enteroenteric fistulas, detection of abdominal 
nodes, perivisceral fat enhancement
Per segment analysis, MRE significantly superior 
to CTE in detecting ileal wall enhancement, with 
higher sensitivity (93% vs 81%) and accuracy 
(88% vs 81%), but lower specificity (72% vs 81%). 
MRE significantly superior in localising rectal 
disease, with higher accuracy (93% vs 85%), 
specificity (100% vs 50,9%) but lower sensitivity 
(72% vs 81%)
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since produced more promising results. A German 
study of 23 patients with suspected IBD, comparing 
MRC using water enemas to colonoscopy findings, 
identified a sensitivity of 87% and specificity of 100% 
for detecting colonic inflammatory changes[47]. Recent 
studies have supported the reliability of diffusion 
weighted imaging MRC (DWI-MRC) for detecting 
colonic inflammation in UC, without the need for bowel 
preparation[48]. Advances in contrast media and DWI-
MRI may increase the sensitivity and role of MRC in 
evaluating colonic inflammation in IBD, particularly 
in patients intolerant to colonoscopy. However, larger 
Jensen et al[71], 2011 Denmark 50 CD Prospective,
multicentre study,
patients with 
symptomatic pre-
existing CD requiring 
small bowel imaging for 
treatment decisions
MRE and CTE 
compared with gold 
standard of ileoscopy 
or surgery
No significant difference between MRE and CTE 
for detection of small bowel CD
MRE: sensitivity 74%, specificity 80%
CTE: sensitivity 83%, specificity 70%
No significant difference for detection of small 
bowel stenosis. MRE: sensitivity 55%, specificity 
92%. CTE: sensitivity 70%, specificity 92%
Chatu et al[50], 2012 United 
Kingdom
143 CD Retrospective study,
single tertiary centre,
all symptomatic patients 
with known or suspected 
CD who underwent 
SICUS retrospectively 
were reviewed
June 2007-Dec 2010
Adult cohort
Mean age 36 yr
SICUS compared 
with SBFT, CT, 
histological findings 
from ileocolonoscopy 
or surgery, and CRP, 
using final diagnosis 
as the reference 
standard
Sensitivity of SICUS in detecting active small 
bowel CD in known or suspected cases 93%, 
specificity 99%, positive predictive value 98%, 
negative predictive value 95%
Agreement between SICUS with SBFT (k = 0.88), 
CT (k = 0.91), histological findings (k = 0.62), 
CRP (k = 0.07)
Pallotta et al[51], 2012 Italy 49 CD Prospective study,
consecutive patients,
adult and paediatric CD 
who underwent resective 
bowel surgery
Jan 2000-Oct 2010
Mean age 37.7 yr
(Age range 12-78 yr)
Conventional 
transabdominal US 
and SICUS compared 
to intraoperative 
and histological 
findings to assess CD 
complications
SICUS ability to: 
Detect at least one stricture: Sensitivity 97.5%, 
specificity 100%, k = 0.93
Detect two or more strictures: Sensitivity 75%, 
specificity 100%, k = 0.78
Detect fistulas: Sensitivity 96%, specificity 90.5%, 
k = 0.88
Detect intra-abdominal abscesses: Sensitivity 
100%, specificity 95%, k = 0.89
Qiu et al[44], 2014 China 290 CD Systematic review 
with meta-analysis 
including six studies, 
all prospective 
with enrollment of 
consecutive CD patients
MRE and CTE in 
detecting active 
small bowel CD and 
complications
Pooled sensitivity MRE in detecting active small 
bowel CD: 87.9%, specificity 81.2%
Pooled sensitivity CTE in detecting active small 
bowel CD 85.8%, specificity 83.6%
No significant difference between MRE and CTE 
in detecting fistula, stenosis and abscesses.
Kumar et al[52], 2015 United 
Kingdom
67 CD Retrospective study,
Single tertiary centre.
Adult cohort (age 
18.8-68.9 yr)
CD patients requiring 
resective bowel surgery 
within 6 mo of SICUS/
MRE investigation 
being performed June 
2007-December 2012
SICUS and MRE 
compared to 
intraoperative 
findings
Sensitivity of SICUS and MRE in detecting: 
Strictures: 87.5%, 100%
Fistulae: 87.7%, 66.7
Abscesses: 100%, 100%
Bowel dilatation: 100%, 66.7%
Bowel wall thickening: 94.7% and 81.8%
Compared with surgery, high level of agreement 
of SICUS, MRE in: 
Localising strictures: k = 0.75, 0.88
Fistulae: k = 0.82, 0.79
Abscesses k = 0.87, 0.77
High level of agreement between SICUS and 
MRE in identifying stricturing disease (k = 0.84), 
number and location of strictures (k = 0.85), 
fistulae (k = 0.65), mucosal thickening (k = 0.61)
Aloi et al[53], 2015 Italy 25 CD Single tertiary centre for 
paediatric IBD
Paediatric cohort with 
known or suspected 
small bowel CD
MRE, SICUS, CE for 
diagnosis of small 
bowel CD
Jejunum: Specificity CE significantly lower 
(61%) than MRE. No significant difference in 
sensitivity: SICUS 92%, CE 92%, MRE (75%)
Proximal and mid-ileum: Specificity CE 
significantly lower. No significant difference in 
sensitivity: MRE 100%, CE 100%, SICUS 80%
Terminal ileum: Sensitivity of SICUS and MRE 
(94%, 94%) higher than CE (81%), CE more 
specific
CD: Crohn’s disease; MRE: Magnetic resonance enterography; CT: Computed tomography; CTE: Computerised tomography enterography; SICUS: Small 
intestine contrast-enhanced ultrasonography; CE: Capsule endoscopy; BE: Barium enteroclysis; SBFT: Small bowel follow-through; US: Ultrasonography; 
MRI: Magnetic resonance imaging.
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scale comparative data is still required.
Trans-abdominal US and small intestine contrast-
enhanced US
Trans-abdominal US has increasingly been favoured 
as a non-invasive imaging tool useful for the diagnosis 
of small bowel CD. It has advantages over SBfT 
in detecting extra-intestinal disease, is more cost 
effective and better tolerated than MRI, and avoids 
the radiation exposure of CT imaging. However, 
conventional trans-abdominal US is often limited by 
the presence of endoluminal gas and collapsed bowel 
walls, which may obscure pathology[49]. Administering 
oral contrast prior to performing US promotes bowel 
loop distension, improving bowel wall visualisation. As 
a consequence, small intestine contrast-enhanced US 
(SICUS) has emerged as a more accurate alternative 
to conventional US for the diagnosis and monitoring of 
small bowel CD[45,49].
A prospective Italian study by Parente et al[49] of 
102 patients with CD, compared conventional US with 
SICUS for the diagnosis of CD and its intraluminal 
complications. Per-segment analysis revealed a 
superior diagnostic accuracy of SICUS in detecting 
small bowel CD. Indeed use of an oral anechoic 
contrast agent resulted in an increase in sensitivity 
from 91.4% to 96.1%[49]. SICUS was also more 
accurate than conventional US in detecting strictures 
and measuring the extent of small bowel involvement. 
Both conventional US and SICUS had a higher 
diagnostic accuracy than SBE in detecting fistulas, 
using intra-operative findings as the gold standard[49]. 
More recently, a United Kingdom-based study of 143 
patients with suspected or known CD, found SICUS 
to have a similar diagnostic yield compared to SBfT 
and CT (k coefficient 0.88 and 0.91 respectively) for 
the detection of features of small bowel CD in routine 
clinical practice[50]. The sensitivity and specificity of 
SICUS for the detection of active small bowel CD 
was 93% and 99% respectively, with a positive 
predictive value of 98% and a negative predictive 
value of 95%. furthermore, there was substantial 
agreement between SICUS and histology obtained at 
ileocolonoscopy or surgery (k = 0.62)[50].
SICUS may also have a role to play in the pre-
operative assessment of CD. A prospective study by 
Pallotta et al[51] of 49 patients with CD, compared 
SICUS with intra-operative findings for the detection 
of small intestinal complications of CD. SICUS 
demonstrated high sensitivity and specificity for the 
detection of small bowel strictures (97.5% sensitivity, 
100% specificity, k = 0.78), fistulas (96% sensitivity, 
90.5% specificity, k = 0.88), and abscesses (100% 
sensitivity, 95% specificity, k = 0.89)[51]. Similarly, 
Kumar et al[52] compared SICUS and MRE in routine 
clinical practice with intra-operative findings in patients 
with CD requiring surgery. Correlating SICUS and MRE 
with surgery, there was a high level of agreement in 
localising strictures (k = 0.75, k = 0.88), fistulae (k = 
0.82, 0.79) and abscesses (k = 0.87, 0.77)[52].
SICUS may be particularly well suited to investi-
gating small bowel CD in children, where routine 
additional challenges include poorer tolerance to 
ileocolonoscopy (IC) requiring general anaesthetic, 
difficulty lying still for a time-consuming MRI, and 
increased sensitivity to ionising radiation. A recent 
prospective study by Aloi et al[53] compared MRE, 
SICUS and video capsule endoscopy in the evaluation 
of 25 children with suspected or known CD. Overall 
there was no significant difference among the three 
imaging modalities for the detection of active small 
bowel CD. Combining diagnostic imaging improved 
collective sensitivities, and combining SICUS with the 
serological marker C-reactive protein increased the 
specificity for the detection of CD from 89% to 100% 
in the jejunum, and from 79% to 100% in the distal 
ileum (p < 0.05)[53].
Preliminary data has suggested a role for power 
Doppler imaging in enhancing the diagnostic accuracy 
of conventional US and SICUS. Power Doppler US 
allows assessment of bowel wall vascularity, which 
has been shown to correlate well with disease activity 
in CD[54]. It can also aid in distinguishing between 
inflammatory and fibrotic stenosis[50].
Overall, SICUS has emerged as an accurate, 
well tolerated, radiation-free imaging tool for the 
assessment of small bowel CD. Limitations include 
inter-observer variability and difficulty interpreting 
and comparing images retrospectively given that it 
is a dynamic procedure. The diagnostic accuracy of 
SICUS is operator dependent and often thought to 
be dependent on experience. Although, in a 2005 
Italian study SICUS performed by a inexperienced 
sonographer achieved superior diagnostic accuracy 
for assessing small bowel CD lesions compared to 
conventional trans-abdominal US performed by an 
experienced sonographer[55]. The results of a large 
multi-centre prospective study comparing MRE with 
US in CD patients are keenly awaited[56].
Contrast enhanced ultrasonography
Contrast enhanced ultrasonography (CEUS) is a 
new technique that involves the administration of an 
intravenous contrast agent, real-time, during ultra-
sonography. It allows more accurate evaluation of 
bowel wall vascularisation. Mural hyper-enhancement 
following contrast in CEUS has been shown to correlate 
well with bowel inflammation and allows grading of 
CD activity[57,58]. CEUS also has the potential additional 
benefit of better distinguishing between inflammatory 
and fibro-stenotic lesions, which can be difficult with 
conventional ultrasound[58]. CEUS does not require 
oral preparation, therefore it is well tolerated by 
patients and can be repeatedly performed to monitor 
disease activity. Limitations include the need for 
specific software, and increased procedure time. 
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Current studies suggest a role for CEUS in monitoring 
treatment response in CD, but further prospective 
studies are required to quantify how well CEUS 
correlates with endoscopic changes and SICUS[57].
CONClUsION
Increased awareness of the cumulative exposure 
of IBD patients to diagnostic medical radiation is 
warranted, particularly given the potential for an 
increased risk of radiation-induced malignancy in 
patients exposed at a younger age. Creation of 
radiation diaries is a useful consideration to log total 
radiation exposures. MRI and SICUS are alternative, 
radiation-free imaging modalities, with proven diag-
nostic accuracy, and should be routinely considered 
for the diagnosis and evaluation of patients with small 
bowel CD wherever possible. More provision is needed 
for out-of-hours radiation-free imaging modalities to 
reduce the need for CT.
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